𝔖 Bobbio Scriptorium

✦ LIBER ✦

Prospective randomized comparative observation of single- versus split-dose lenograstim to enhance engraftment after autologous stem cell transplantation in patients with multiple myeloma or non-Hodgkin's lymphoma

✍ Scribed by Geundoo Jang; Ock Bae Ko; Shin Kim; Dae Ho Lee; Jooryung Huh; Cheolwon Suh

Book ID: 109143962
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 195 KB
Volume: 48
Category: Article
ISSN: 0372-1248
DOI: 10.1111/j.1537-2995.2007.01588.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective randomized comparative obser

Prospective randomized comparative observation of single- vs split-dose lenograstim to mobilize peripheral blood progenitor cells following chemotherapy in patients with multiple myeloma or non-Hodgkin’s lymphoma

✍ Shin Kim; Hyo-Jung Kim; Jung Sun Park; Jungsin Lee; Hyun-Sook Chi; Chan Jeong Pa 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 98 KB

Design of the EXercise Intervention afte

Design of the EXercise Intervention after Stem cell Transplantation (EXIST) study: a randomized controlled trial to evaluate the effectiveness and cost-effectiveness of an individualized high intensity physical exercise program on fitness and fatigue in patients with multiple myeloma or (non-) Hodgkin's lymphoma treated with high dose chemotherapy and autologous stem cell transplantation

✍ Saskia Persoon; Marie José Kersten; Mai JM ChinAPaw; Laurien M Buffart; Heleen B 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 256 KB

79: Pegfilgrastim (P) Appears to be Equi

79: Pegfilgrastim (P) Appears to be Equivalent to Multiple Daily Doses of Filgrastim (F) to Treat Neutropenia Post-Autologous Peripheral Blood Stem Cell Transplant (PBSCT) in Patients with Non-Hodgkin's Lymphoma: Results of a Randomized Phase II Trial

✍ R. Rifkin; R. Beveridge; G. Spitzer; G. Orloff; R. Mandanas; D. McGaughey; F. Zh 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB

High dose therapy and autologous stem ce

High dose therapy and autologous stem cell transplant does not improve survival compared with continued combination chemotherapy in people at high risk of relapse after initial treatment of advanced Hodgkin’s lymphoma: Abstracted from: Federico M, Bellei M, Brice P et al. High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy. Journal of Clinical Oncology 2003; 21: 2320–2325

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 83 KB